drugset / Trial / NCT00120783

Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance

NCT00120783

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study investigated whether a calibrated reduction in antiretroviral drug pressures could stabilize the evolution and the pathogenic potential of resistant HIV viruses.

Timeline

Start
2002-02
Primary completion
Completion
2003-08

Drugs

EvaluationDrugModalityDoseRoute
Subject INDINAVIR ANHYDROUS Other / unclassified 200 mg
Subject Lamivudine Other / unclassified 150 mg
Subject Ritonavir Other / unclassified 100 mg